The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Tamzeltos 400 micrograms prolonged-release tablets

KRKA, d.d., Novo mestoPA1347/087/001

Main Information

Trade NameTamzeltos 400 micrograms prolonged-release tablets
Active SubstancesTamsulosin hydrochloride
Dosage FormProlonged-release tablet
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/087/001

Group Information

ATC CodeG04CA Alpha-adrenoreceptor antagonists
G04CA02 tamsulosin


License statusAuthorised
Licence Issued29/11/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0024-066-024
Interchangeable List DocumentPDF of Interchangeable List
« Back